| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |